• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Beta blocker for patients with pulmonary arterial hypertension: A single center experience.

作者信息

Moretti Claudio, Grosso Marra Walter, D'Ascenzo Fabrizio, Omedè Pierluigi, Cannillo Margherita, Libertucci Daniela, Fusaro Enrico, Meynet Ilaria, Giordana Francesca, Salera Davide, Annone Umberto, Chen S L, Marra Sebastiano, Gaita Fiorenzo

机构信息

Division of Cardiology, University of Turin, Città Della Salute e Della Scienza, Turin, Italy.

Division of Cardiology, University of Turin, Città Della Salute e Della Scienza, Turin, Italy.

出版信息

Int J Cardiol. 2015 Apr 1;184:528-532. doi: 10.1016/j.ijcard.2015.02.033. Epub 2015 Feb 24.

DOI:10.1016/j.ijcard.2015.02.033
PMID:25767009
Abstract
摘要

相似文献

1
Beta blocker for patients with pulmonary arterial hypertension: A single center experience.肺动脉高压患者使用β受体阻滞剂：单中心经验
Int J Cardiol. 2015 Apr 1;184:528-532. doi: 10.1016/j.ijcard.2015.02.033. Epub 2015 Feb 24.
2
Usefulness of beta-blocker therapy and outcomes in patients with pulmonary arterial hypertension.β受体阻滞剂治疗在肺动脉高压患者中的作用及疗效。
Am J Cardiol. 2012 May 15;109(10):1504-9. doi: 10.1016/j.amjcard.2012.01.368. Epub 2012 Mar 3.
3
[Pulmonary hypertension and right ventricular failure. Part XI. Endothelin receptor blockers in the treatment of primary pulmonary arterial hypertension].[肺动脉高压与右心室衰竭。第十一章。内皮素受体阻滞剂治疗原发性肺动脉高压]
Kardiologiia. 2007;47(7):73-82.
4
Endothelin-1 receptor antagonists in fetal development and pulmonary arterial hypertension.内皮素-1受体拮抗剂在胎儿发育和肺动脉高压中的作用
Reprod Toxicol. 2015 Aug 15;56:45-51. doi: 10.1016/j.reprotox.2015.06.048. Epub 2015 Jun 22.
5
Use of β-Blockers in Pulmonary Hypertension.β受体阻滞剂在肺动脉高压中的应用。
Circ Heart Fail. 2017 Apr;10(4). doi: 10.1161/CIRCHEARTFAILURE.116.003703.
6
[Pulmonary arterial hypertension. Therapy with the endothelin-1 receptor antagonist bosentan].[肺动脉高压。内皮素-1受体拮抗剂波生坦的治疗]
Med Monatsschr Pharm. 2006 Jul;29(7):242-5.
7
Acute hemodynamic effects of single oral dose of bosentan in patients with pulmonary arterial hypertension related to congenital heart disease.单剂量口服波生坦对先天性心脏病相关肺动脉高压患者的急性血流动力学影响。
Congenit Heart Dis. 2014 Jul-Aug;9(4):343-8. doi: 10.1111/chd.12147.
8
Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension.比索洛尔可延缓实验性肺动脉高压向右心衰竭的进展。
Circ Heart Fail. 2012 Jan;5(1):97-105. doi: 10.1161/CIRCHEARTFAILURE.111.964494. Epub 2011 Dec 9.
9
Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.比索洛尔改善肺动脉高压的内皮功能障碍、肺血管重构和右心功能。
J Am Coll Cardiol. 2015 Feb 24;65(7):668-80. doi: 10.1016/j.jacc.2014.11.050.
10
The right ventricle in pulmonary hypertension.
Coron Artery Dis. 2005 Feb;16(1):13-8. doi: 10.1097/00019501-200502000-00003.

引用本文的文献

1
Pulmonary Hypertension: Pharmacological and Non-Pharmacological Therapies.肺动脉高压：药物及非药物治疗方法
Life (Basel). 2024 Oct 4;14(10):1265. doi: 10.3390/life14101265.
2
Pulmonary Arterial Hypertension in the Elderly: Peculiar Features and Challenges for a Proper Phenotyping Approach.老年肺动脉高压：独特特征及准确表型分析方法面临的挑战
J Cardiovasc Dev Dis. 2023 Sep 18;10(9):401. doi: 10.3390/jcdd10090401.
3
Neurohormonal Modulation as a Therapeutic Target in Pulmonary Hypertension.神经激素调节作为肺动脉高压的治疗靶点。
Cells. 2020 Nov 22;9(11):2521. doi: 10.3390/cells9112521.
4
Interdependence of hypoxia and β-adrenergic receptor signaling in pulmonary arterial hypertension.低氧与β肾上腺素能受体信号在肺动脉高压中的相互依赖关系。
Am J Physiol Lung Cell Mol Physiol. 2019 Sep 1;317(3):L369-L380. doi: 10.1152/ajplung.00015.2019. Epub 2019 Jun 26.
5
Pulmonary artery denervation: a novel treatment modality for pulmonary hypertension.肺动脉去神经支配术：一种治疗肺动脉高压的新方法。
J Thorac Dis. 2019 Apr;11(4):1094-1096. doi: 10.21037/jtd.2019.02.93.
6
Neurohormonal modulation as therapeutic avenue for right ventricular dysfunction in pulmonary artery hypertension: till the dawn, waiting.神经激素调节作为肺动脉高压右心室功能障碍的治疗途径：直至黎明，等待中。
Ann Transl Med. 2018 Aug;6(15):301. doi: 10.21037/atm.2018.06.04.
7
Autonomic nervous system involvement in pulmonary arterial hypertension.自主神经系统参与肺动脉高压。
Respir Res. 2017 Dec 4;18(1):201. doi: 10.1186/s12931-017-0679-6.
8
Neurohormonal activation and pharmacological inhibition in pulmonary arterial hypertension and related right ventricular failure.肺动脉高压及相关右心室衰竭中的神经激素激活与药物抑制
Heart Fail Rev. 2016 Sep;21(5):539-47. doi: 10.1007/s10741-016-9566-3.